logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Monitoring of inflammatory complications development in the newborns with congenital pathology of the gastrointestinal tract

[Original research] [Pediatrics]
Sergey Minaev; Chersi Gudiev; Sergey Timofeev; Tamara Khoranova; Elena Lukyanenko; Elena Tovkan; Alesya Isaeva; Alexandr Obedin; Igor Kirgizov; Natalya Getman;

The level of protein binding fatty acid (I-FABP, «BCM Diagnostics») in blood serum was investigated in 24 infants with congenital high and low intestinal obstruction on 0, 1, 3, 7, 14 days. All children underwent surgical correction of the defect in the first and second days after diagnosis. I-FABP level in children before surgery in group 1 (with purulent-inflammatory complications) (Me: 71.9 ng/ml, interquartile range P25–P75: 100 ng/ml) was significantly (p=0.0031) higher than the corresponding figures in a control group (Me: 24.95 ng/ml P25–P75: 52.25 ng/ml). By the 14th day the difference of I-FABP indicators in group 1 and group 2 (no postoperative complications) was as follows: Me: 197.50 ng/ml, P25–P75: 75.6 ng/ml and Me: 45.36 ng/ml, P25–P75: 52.2 ng/ml, respectively. To assess the condition of newborns with malformations of the gastrointestinal tract following surgery it is necessary to study I-FABP, which is a marker of damage of the small intestine epithelial cells.

Download

References:
1. Akhmadeyeva E.N., Fatykhova A.I. Infuzionnaya terapiya i parenteralnoye pitaniye v neonatologii. Ufa: «VerteX»; 2005. P.1-34.
2. Drozdov V.N., Li I.A., Varvanina G.G., Tkachenko Ye.V. Eksperimentalnaya i klinicheskaya gastroenterologiya. – Experemental and clinical gastroenterology. 2011;5:35-37.
3. Minaev S.V., Obedin A.N., Bolotov Yu.N., Tovkan Ye.A., Isaeva A.V., Khoranova T.A., Tokhchukov R.M, Stepanova Ye.V. Pediatricheskaya farmakologiya. – Pediatric pharmacology. 2012;9(3):65-67.
4. Obedin A.N., Minaev S.V., Murav’eva A.A. Meditsinskii Vestnik Sevrnogo kavkaza. – Medical News of North Caucasus. 2011;3:11-13.
5. Berman L., Moss R.L. Semin. Fetal Neonatal Med. 2011;20:1164-1168.
6. Cronk D.R., Houseworth T.P., Cuadrado D.G. et al. Curr Surg. 2006;63(5):322-325.
7. Evennett N., Alexander N., Petrov M. et al. J Pediatr Surg. 2009;44(11):2192-2201.
8. Evennett N.J., Petrov M.S., Mittal A., Windsor J.A. World J Surg. 2009;33(7):1374-1383.
9. Li Х., Morokuma S., Fukushima K. et al. BMC Pregnancy Childbirth. 2011;22:11-32.
10. Mohiuddin M.W., Resig P.P., Sexton K.W., Douglas W.I. ASAIO J. 2011;57(3):225-230.
11. Thuijls G., van Wijck K., Grootjans J. et al. Ann Surg. 2011;253(2):303-308.
12. Watanabe T., Nakano M., Yamazawa K. et al. Surg Today. 2011;41(5):726-729.

Keywords: newborn, gastrointestinal tract, congenital malformations, I-FABP


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy